Caplin Point LaboratoriesNSE:CAPLIPOINT 94 Days Inventory is 159.73 as of Mar. 2026, which is 17% above its 10-year median of 136.80. GuruFocus rates NSE:CAPLIPOINT with a GF Score™ of 94/100 and a GF Value™ of ₹2,081.07 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 919 Drug Manufacturers companies, Caplin Point Laboratories ranks better than 54.95% on this metric.
The historical rank and industry rank for Caplin Point Laboratories's Days Inventory or its related term are showing as below:
NSE:CAPLIPOINT'
s Days Inventory Range Over the Past 10 Years
Min: 38.65 Med: 136.8 Max: 165.52
Current: 153.81
During the past 13 years, Caplin Point Laboratories's highest Days Inventory was 165.52. The lowest was 38.65. And the median was 136.80.
NSE:CAPLIPOINT's Days Inventory is ranked better than 54.95% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs NSE:CAPLIPOINT: 153.81
Inventory Turnover measures how fast the company turns over its inventory within a year.
Caplin Point Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.57.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Caplin Point Laboratories's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.71.
Caplin Point Laboratories (NSE:CAPLIPOINT) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Caplin Point Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Caplin Point Laboratories's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Caplin Point Laboratories Days Inventory Related Terms
Caplin Point Laboratories Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CAPLIPOINT vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Caplin Point Laboratories Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's Days Inventory distribution charts can be found below:
* The bar in red indicates where Caplin Point Laboratories's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Caplin Point Laboratories (NSE:CAPLIPOINT) has a Days Inventory of 159.73 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Caplin Point Laboratories and its competitors. This is 17% above median its historical median of 136.80. Over the past decade, Caplin Point Laboratories' Days Inventory has ranged from 38.65 to 165.52. According to the industry distribution chart, Caplin Point Laboratories ranks #414 out of 919 companies in the Drug Manufacturers industry, placing it in the top 45%.
Is Caplin Point Laboratories' Days Inventory too high?
Caplin Point Laboratories' current Days Inventory of 159.73 is 17% above median its 10-year median of 136.80. Over the past 10 years, this metric has ranged from a low of 38.65 to a high of 165.52. The Drug Manufacturers industry median Days Inventory is 164.48. Caplin Point Laboratories' value of 159.73 is 2.9% below this industry median. Based on the distribution chart, Caplin Point Laboratories ranks #414 out of 919 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Caplin Point Laboratories has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Caplin Point Laboratories' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Caplin Point Laboratories ranks #414 out of 919 companies for Days Inventory. This puts Caplin Point Laboratories in the upper half of its industry. The industry median Days Inventory is 164.48. Caplin Point Laboratories' value of 159.73 is 2.9% below this benchmark. Historically, Caplin Point Laboratories' own Days Inventory has ranged from 38.65 to 165.52 over the past decade. While the company's 10-year median is 136.80 vs. the industry median of 164.48, Caplin Point Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Caplin Point Laboratories's current Days Inventory of 159.73 is 2.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Caplin Point Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Caplin Point Laboratories's current Days Inventory is 159.73, which is 17% above median its own 10-year median of 136.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caplin Point Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Caplin Point Laboratories (NSE:CAPLIPOINT) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹2,081.07, compared to a current price of ₹2,538.10 — trading 22% above its estimated fair value. The current Days Inventory is 159.73, which is 17% above median its 10-year median of 136.80 and 2.9% below the Drug Manufacturers industry median of 164.48. Caplin Point Laboratories' overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Caplin Point Laboratories (NSE:CAPLIPOINT), the current Days Inventory is 159.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Caplin Point Laboratories (NSE:CAPLIPOINT) Overvalued in 2026?
Based on GuruFocus' analysis, Caplin Point Laboratories stock appears to be overvalued.
The current stock price of ₹2,538.10 is trading 22% above its estimated GF Value™ of ₹2,081.07.
GuruFocus considers Caplin Point Laboratories to be Modestly Overvalued.
Key valuation signals for NSE:CAPLIPOINT:
Days Inventory: 159.73 (17% above median its 10-year median of 136.80)
GF Value™: ₹2,081.07 vs. price of ₹2,538.10 (22% above fair value)
Industry Position: 2.9% below the Drug Manufacturers median (#414 of 919)
No single metric tells the full story. See the NSE:CAPLIPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, injections (liquid and lyophilized, prefilled syringes), ophthalmic solutions, liquid orals, soft gel capsules, ointments, creams, gels, powders for injections, suppositories, ovules, pre-mix bag formulations, inhalers, sprays, and IV infusions. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops.
94GF Score
Get the complete analysis for NSE:CAPLIPOINT
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CAPLIPOINT has been successfully added to your 
